BQ323636.1, a novel splice variant to NCOR2, as a predictor for tamoxifen resistant breast cancer
Purpose: Adjuvant tamoxifen treatment revolutionized the management of estrogen receptor (ER) positive breast cancers to prevent cancer recurrence; however drug resistance compromises its clinical efficacy. The mechanisms underlying tamoxifen resistance are not fully understood and no robust biomark...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
American Association for Cancer Research
2018
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/48935/ |